(0.05%) 5 520.00 points
(0.17%) 39 910 points
(0.08%) 19 767 points
(0.02%) $81.65
(0.46%) $2.82
(-0.23%) $2 339.00
(0.17%) $29.58
(0.62%) $1 008.00
(0.11%) $0.932
(-0.12%) $10.52
(0.03%) $0.788
(-0.85%) $87.25
0.00% $ 13.29
Live Chart Being Loaded With Signals
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company\'s precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach...
Stats | |
---|---|
Dzisiejszy wolumen | 1.79M |
Średni wolumen | 725 973 |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.550 ( Q3 | 2022-11-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-4.69 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.438 (3.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-11-30 | Walker Paul Edward | Sell | 4 294 207 | Common Stock |
2022-11-30 | Sonsini Peter W. | Sell | 4 294 207 | Common Stock |
2022-11-30 | Sandell Scott D | Sell | 4 294 207 | Common Stock |
2022-12-01 | Mathers Edward T | Sell | 16 000 | Stock Option (right to buy) |
2022-11-30 | Makhzoumi Mohamad | Sell | 4 294 207 | Common Stock |
INSIDER POWER |
---|
-17.62 |
Last 97 transactions |
Buy: 48 602 836 | Sell: 208 882 585 |
Wolumen Korelacja
Akouos, Inc. Korelacja
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Akouos, Inc. Korelacja - Waluta/Towar
Akouos, Inc. Finanse
Annual | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-4.94 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-4.94 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.77 |
FY | 2019 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.65 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Akouos, Inc.
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company\'s precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej